Plethico Pharmaceuticals (Delisted) bulk deals, insider trading and stake changes

BSE: 532739

Last traded ₹9.05 on 13 Jun 2016

Delisted on 11 May 2018.

Plethico Pharmaceuticals insider trading

All 5 disclosures on record. The company's own latest disclosure on record is from Jul 2016.Insider trading, all companies

  1. Jun 2016

    • Shashikant Patel2,50,000sharesInvoked · Promoter · 8 Jun 2016 · disclosed 29 Jul · Pledge Invoked · held 1,91,38,472 before, holds 1,88,88,472 after

  2. Apr 2016

    • SHASHIKANT PATEL1,40,000sharesInvoked · Promoters · 25 Apr 2016 · disclosed 26 Apr · Invocation of pledge · held 1,92,78,472 before, holds 1,91,38,472 after

  3. Mar 2016

    • Shashikant Patel30,80,000sharesInvoked · Promoter · 18 Mar 2016 · disclosed 21 Mar · Invocation Of Pledged · held 2,23,58,472 before, holds 1,92,78,472 after

  4. Dec 2015

    • Shashikant Patel10,00,000sharesInvoked · Promoter · 30 Dec 2015 · disclosed 21 Mar 2016 · Invocation Of Pledged · held 2,33,58,472 before, holds 2,23,58,472 after

  5. Aug 2015

    • Shashikant Patel1,30,000sharesInvoked · Promoter · 1 Aug 2015 · disclosed 21 Mar 2016 · Invocation Of Pledged · held 2,34,88,472 before, holds 2,33,58,472 after

Trades by the company's promoters, directors, key managers, employees and their relatives, as each disclosed them. Value is what the filer stated; the mode is shown where the shares moved off the market.

Plethico Pharmaceuticals stake sales and purchases

All 7 disclosures on record.

  1. Apr 2016

    • SoldSICOM Ltd8.28% of the company28,21,754 sharesholds 0.29% after22 Apr 2016 · filed under the 2% rule · Market

  2. Nov 2012

    • SoldIDBI Trusteeship Services Ltd84,49,000 shares2 Nov 2012 · filed under the 2% rule · Release of Shares

  3. Oct 2012

    • SoldShashikant Patel · promoter2.05% of the company7,00,000 sharesholds 81.16% after3 Oct 2012 · filed under the 2% rule · Pledge Invoked

  4. Aug 2012

    • SoldArum Investments Pvt Ltd & Others876 sharesholds 23.19% after11 Aug 2012 · filed under the 2% rule · Market

  5. Sep 2010

    • AcquiredIDBI Trusteeship Services Ltd1.29% of the company4,39,000 sharesholds 14.50% after2 Sep 2010 · filed under the 1997 takeover rules · Pledge
    • AcquiredIDBI Truststeeship Services Ltd4,39,000 shares1 Sep 2010 · filed under the 1997 takeover rules · Pledge

  6. Aug 2010

    • AcquiredIDBI Trusteeship Services Ltd13.21% of the company45,00,000 sharesholds 13.21% after25 Aug 2010 · filed under the 1997 takeover rules · Pledge

The 5% rule: an investor discloses on reaching 5% of the company. The 2% rule: a holder of 5% or more discloses each change of 2% or more, including one that takes it below 5%. A transfer exempt from an open offer, the offer to buy from every other shareholder that a large purchase otherwise brings, is disclosed too. Each line shows what its filing states, which can be a smaller change than its rule names.

Plethico Pharmaceuticals bulk deals

ValuePer cent of the company

Thursday 26 Nov 20151 firm · ₹0 bought · ₹0.31 Cr soldNet sold ₹0.31 Cr
  • SoldSICOM LIMITEDSold 2,93,000 at ₹10.720.86% of the company₹0.31 Cr
Wednesday 12 Nov 20141 firm · ₹0 bought · ₹0.78 Cr soldNet sold ₹0.78 Cr
  • SoldSICOM LTDSold 1,91,000 at ₹41.000.56% of the company₹0.78 Cr
Friday 12 May 20061 firm · ₹8.43 Cr bought · ₹0 soldNet bought ₹8.43 Cr
  • BoughtGOLDMAN SACHS INVESTMENT (MAURITIUS) 1 LIMITED A/C SHORT TERMBought 2,08,120 at ₹404.86₹8.43 Cr

A bulk deal is one client trading half a per cent or more of the shares in a day; a block deal is a large trade in the exchange's separate block window, its buyer and its seller each on a line of their own. A firm that bought and sold the shares the same day is on one line, with its net. All 3 deals on record since listing on 5 May 2006.